METHODS OF TREATING NEUROFIBROMATOSIS TYPE 1 AND RELATED CONDITIONS WITH ALKALINE PHOSPHATASE | Patent Publication Number 20210162023
US 20210162023 A1Publication DateJun 3, 2021
Original Assignee
Current AssigneeAlexion Pharmaceuticals
Inventor/ApplicantsAnna PETRYK
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.